Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vanessa Drendel

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Forensic Science International|June 23, 2012
Suicide of a man with known allergy to fish protein by ingesting tinned fishVera Sterzik, Vanessa Drendel, Michael Will, et al.
Springerplus|September 22, 2016
Single punch, double biopsyMalte Krönig, Norbert Nanko, Vanessa Drendel, et al.
Clinical Proteomics|August 9, 2018
Proteomic distinction of renal oncocytomas and chromophobe renal cell carcinomasVanessa Drendel, Bianca Heckelmann, Christoph Schell, et al.
EJNMMI Research|June 14, 2020
Voxel-based comparison of [<sup>68</sup>Ga]Ga-RM2-PET/CT and [<sup>68</sup>Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancerThomas Franz Fassbender, Florian Schiller, Constantinos Zamboglou, et al.
Nuclear Medicine and Biology|March 6, 2019
Accuracy of [<sup>68</sup>Ga]Ga-RM2-PET/CT for diagnosis of primary prostate cancer compared to histopathologyThomas F Fassbender, Florian Schiller, Michael Mix, et al.
Neoplasia (New York, N.Y.)|December 18, 2017
Proteomic Characterization of Prostate Cancer to Distinguish Nonmetastasizing and Metastasizing Primary Tumors and Lymph Node MetastasesAnn-Kathrin Müller, Melanie Föll, Bianca Heckelmann, et al.
World Journal of Surgical Oncology|February 23, 2017
Diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancerMalte Krönig, Christian Haverkamp, Antonia Schulte, et al.
Oncotarget|December 17, 2017
Proteome profiling of clear cell renal cell carcinoma in von Hippel-Lindau patients highlights upregulation of Xaa-Pro aminopeptidase-1, an anti-proliferative and anti-migratory exoproteaseVanessa Drendel, Bianca Heckelmann, Chia-Yi Chen, et al.
Theranostics|May 23, 2017
Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate CancerCordula A Jilg, Vanessa Drendel, H Christian Rischke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 1, 2018
Performance of <sup>111</sup>In-labelled PSMA ligand in patients with nodal metastatic prostate cancer: correlation between tracer uptake and histopathology from lymphadenectomyMichael Mix, Kathrin Reichel, Christian Stoykow, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Forensic Science International|June 23, 2012
Suicide of a man with known allergy to fish protein by ingesting tinned fishVera Sterzik, Vanessa Drendel, Michael Will, et al.
Springerplus|September 22, 2016
Single punch, double biopsyMalte Krönig, Norbert Nanko, Vanessa Drendel, et al.
Clinical Proteomics|August 9, 2018
Proteomic distinction of renal oncocytomas and chromophobe renal cell carcinomasVanessa Drendel, Bianca Heckelmann, Christoph Schell, et al.
EJNMMI Research|June 14, 2020
Voxel-based comparison of [<sup>68</sup>Ga]Ga-RM2-PET/CT and [<sup>68</sup>Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancerThomas Franz Fassbender, Florian Schiller, Constantinos Zamboglou, et al.
Nuclear Medicine and Biology|March 6, 2019
Accuracy of [<sup>68</sup>Ga]Ga-RM2-PET/CT for diagnosis of primary prostate cancer compared to histopathologyThomas F Fassbender, Florian Schiller, Michael Mix, et al.
Neoplasia (New York, N.Y.)|December 18, 2017
Proteomic Characterization of Prostate Cancer to Distinguish Nonmetastasizing and Metastasizing Primary Tumors and Lymph Node MetastasesAnn-Kathrin Müller, Melanie Föll, Bianca Heckelmann, et al.
World Journal of Surgical Oncology|February 23, 2017
Diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancerMalte Krönig, Christian Haverkamp, Antonia Schulte, et al.
Oncotarget|December 17, 2017
Proteome profiling of clear cell renal cell carcinoma in von Hippel-Lindau patients highlights upregulation of Xaa-Pro aminopeptidase-1, an anti-proliferative and anti-migratory exoproteaseVanessa Drendel, Bianca Heckelmann, Chia-Yi Chen, et al.
Theranostics|May 23, 2017
Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate CancerCordula A Jilg, Vanessa Drendel, H Christian Rischke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 1, 2018
Performance of <sup>111</sup>In-labelled PSMA ligand in patients with nodal metastatic prostate cancer: correlation between tracer uptake and histopathology from lymphadenectomyMichael Mix, Kathrin Reichel, Christian Stoykow, et al.
Pageof 3